4d
Live Science on MSNHims & Hers Super Bowl controversy: What the ad left out about its 'alternative' weight-loss drugsThe telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide medications aren't FDA-approved.
Tri-Union Seafoods issued the voluntary recall on the products Friday out of "an abundance of caution" over botulism risk.
A clinical trial comparing a one-page medication handout proposed by the U.S. Food and Drug Administration (FDA) with an ...
Over 35 years after the first study linking Red 3 to thyroid cancer in rats was published, the US is beginning to wean it out of foods and drugs.
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction of a first-in-class non-opioid analgesic designed to treat moderate to ...
A judge ordered federal health agencies Tuesday to restore online datasets taken down after President Trump issued an ...
It is critical that agencies mandated to protect public health, such as the Food and Drug Administration (FDA), maintain their authority to ensure these products meet high safety standards that ...
Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out the advertisement of prescriptions for injectable weight-loss drugs without ...
Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
Explaining America’s weirdly complicated food inspection system, including who regulates poultry and eggs and how Robert F. Kennedy Jr. is involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results